Leukemia Treatment Provides New Insights Into T-cells

Leukemia treatment provides new insights into therapy. Researchers at the University of Pennsylvania have found that extracting T-cells from patients with chronic lymphocytic leukemia (CLL) could be grown in tissue culture. Subsequent replacement for those cells attack the cancerous cells both in the blood and the bone marrow. The doctors had genetically modified the T-cells to both multiply and selectively destroy the abnormal blood cells.

By altering T-cells, many different diseases can be counteracted through enhancing immunity. This can be applied to iritis, uveitis, herpes, and optic neuritis, all of which may otherwise become recurrent for chronic diseases.